Author:
Arrichiello Gianluca,Pirozzi Mario,Facchini Bianca Arianna,Facchini Sergio,Paragliola Fernando,Nacca Valeria,Nicastro Antonella,Canciello Maria Anna,Orlando Adele,Caterino Marianna,Ciardiello Davide,Della Corte Carminia Maria,Fasano Morena,Napolitano Stefania,Troiani Teresa,Ciardiello Fortunato,Martini Giulia,Martinelli Erika
Abstract
Traditionally, lymph node metastases (LNM) evaluation is essential to the staging of colon cancer patients according to the TNM (tumor–node–metastasis) system. However, in recent years evidence has accumulated regarding the role of emerging pathological features, which could significantly impact the prognosis of colorectal cancer patients. Lymph Node Ratio (LNR) and Log Odds of Positive Lymph Nodes (LODDS) have been shown to predict patients’ prognosis more accurately than traditional nodal staging and it has been suggested that their implementation in existing classification could help stratify further patients with overlapping TNM stage. Tumor deposits (TD) are currently factored within the N1c category of the TNM classification in the absence of lymph node metastases. However, studies have shown that presence of TDs can affect patients’ survival regardless of LNM. Moreover, evidence suggest that presence of TDs should not be evaluated as dichotomic but rather as a quantitative variable. Extranodal extension (ENE) has been shown to correlate with presence of other adverse prognostic features and to impact survival of colorectal cancer patients. In this review we will describe current staging systems and prognostic/predictive factors in colorectal cancer and elaborate on available evidence supporting the implementation of LNR/LODDS, TDs and ENE evaluation in existing classification to improve prognosis estimation and patient selection for adjuvant treatment.
Reference81 articles.
1. Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021
2. Colorectal cancer statistics, 2017;Siegel;CA Cancer J Clin,2017
3. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021
4. TNM classification of malignant tumours, 8 th edition due december 2016;Brierley;Union Int Cancer Control,2017
5. AJCC 8th edition: colorectal cancer;Weiser;Ann Surg Oncol United States,2018